Author:
Høilund-Carlsen Poul F.,Revheim Mona-Elisabeth,Costa Tommaso,Alavi Abass,Kepp Kasper P.,Sensi Stefano L.,Perry George,Robakis Nikolaos K.,Barrio Jorge R.,Vissel Bryce
Subject
Neurology,Molecular Biology,Aging,Biochemistry,Biotechnology
Reference69 articles.
1. Correction for partial volume effect is a must, not a luxury, to fully exploit the potential of quantitative PET imaging in clinical oncology;Alavi;Mol. Imaging Biol.,2018
2. Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer's disease: why it is time to abandon the approach;Alavi;Eur. J. Nucl. Med Mol. Imaging,2020
3. Accelerated brain volume loss caused by anti-β-amyloid drugs: a systematic review and meta-analysis;Alves;Neurology,2023
4. Crenezumab secondaries negative; gantenerumab OLE hints at efficacy;Alzforum;Crenezumab Second. Negat. ; Gantenerumab OLE Hints Effic. | ALZFORUM,2022
5. Response to van Dyck, O'Dell, & Mecca letter to the editor regarding Andrews et al. (2019);Andrews;Alzheimers Dement (N. Y),2023
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献